InfieldHealth
Infield was founded in 2009 in Washington DC. We create mobile technology exclusively for the healthcare space.
Management
Douglas Naegele is the President and founder of Infield. He is chiefly responsible for partner and new product development. He is based in Washington DC.
His past healthcare experience includes drug design and development at Vertex Pharmaceuticals. At Vertex, he participated in the creation of many compounds aimed at immunosuppression and Hepatitis C — and is a co-inventor of three specific compounds. One of those inventions went on to become an FDA approved treatment for Hepatitis C: Incivek (telaprevir).
Douglas also worked in finance at Fannie Mae, and then at the National Cooperative Bank. At Fannie Mae, he was responsible for integrating start-up technology firms into the company’s larger technology offerings. At NCB, he was on the healthcare finance team.
Douglas holds an MBA from The George Washington University and an undergraduate degree from Harvard.
Advisory Board
Andre Blackman is a highly influential and connected agent of change and innovation within the public health and social entrepreneurship community. He is very passionate about the intersection of media, technology and useful innovative concepts as it relates to the improvement of public health and social change, as well as the impact that result from these new ideas. His exposure to key players/leaders in the entrepreneurial, health innovation and social change arenas keeps him well positioned on cutting edge of what’s to come.
Through his health innovation consultancy, Pulse + Signal, Andre helps clients move their brands and initiatives forward through research/insights, digital PR & strategy and effective offline engagement.
Veena R. Kumar, MD holds a BA in Biology from CUNY-Hunter College, an MD from SUNY-Health Sciences Center at Brooklyn, and a Master’s in Public Health from Boston University. She completed her residency in Pediatrics at Yale-New Haven Hospital followed by a fellowship in Pediatric Emergency Medicine at Rhode Island Hospital.
Veena has worked as an attending physician in the pediatric emergency departments of Yale-New Haven Hospital and Boston Children’s Hospital. After 15 years of medical practice, she shifted her career to work in the biotechnology industry. She is currently a Director in Medical and Scientific Affairs at MedImmune.
Carol Torgan, Ph.D. is an award-winning health scientist, strategist, educator, and consultant with more than 15 years of experience in public health and medicine. She received her Ph.D. in Kinesiology and was a Research Associate and Assistant Research Professor in the Division of Cardiology at Duke University Medical Center’s Department of Medicine in North Carolina.
Carol continued her research career at the National Heart, Lung, and Blood Institute, a part of the National Institutes of Health (NIH), in Bethesda, Md. She had the honor of training in the Laboratory of Biochemical Genetics, whose laboratory chief was Nobel Laureate Marshall Nirenberg, discoverer of the genetic code. While at NIH, Carol traded in the lab bench for a lap top in order to translate scientific information to a broader audience.
Carol currently consults on a range of health-focused projects that include developing online interactive educational programs for teens, crafting evidence-based content for health professionals and patients, and advising on digital strategy and social media for government and not-for-profit organizations. She has been interviewed and quoted by numerous major media outlets, including the Washington Post, Los Angeles Times, Forbes, WebMD, Parade, Self, Medical News Today, Real Simple, Reuters, and USA Today. You can learn more and reach her at www.caroltorgan.com.